These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8320124)

  • 1. [Comment on the contribution by G. Fierlbeck, B. d'Hoedt, W. Stroebel, H. Stutte, O. Bogenschütz and G. Rassner. Intralesional therapy of melanoma metastases with recombinant interferon-beta].
    Kölmel KF; Abel U
    Hautarzt; 1993 May; 44(5):329-30. PubMed ID: 8320124
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intralesional therapy of melanoma metastases with recombinant interferon-beta].
    Fierlbeck G; d'Hoedt B; Stroebel W; Stutte H; Bogenschütz O; Rassner G
    Hautarzt; 1992 Jan; 43(1):16-21. PubMed ID: 1612904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bowenoid actinic keratosis: therapy with intralesional injection of recombinant beta-interferon].
    Kowalzick L; Mensing H; Weyer U; Kimmig W; Brzoska J
    Hautarzt; 1992 Jun; 43(6):373-5. PubMed ID: 1628972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interferon therapy in malignant melanoma].
    Stadler R; Garbe C
    Z Hautkr; 1990 May; 65(5):504-7. PubMed ID: 1696048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intralesional therapy of metastatic spreading melanoma with beta-interferon.
    Rapprich H; Hagedorn M
    J Dtsch Dermatol Ges; 2006 Sep; 4(9):743-6. PubMed ID: 16928243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comment on the contribution by U. Beiteke et al. Adjuvant therapy of primary malignant melanoma with natural human interferon-beta. Second comment].
    Gefeller O; Kleeberg U; Kölmel KF
    Hautarzt; 1994 Mar; 45(3):191-2; author reply 193-4. PubMed ID: 8175352
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comment on the contribution by U. Beiteke et al. Adjuvant therapy of primary malignant melanoma with natural human interferon-beta. First comment].
    Windeler J; Lange S; Trampisch HJ
    Hautarzt; 1994 Mar; 45(3):189-90; author reply 193-4. PubMed ID: 8175351
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon-beta therapy for malignant melanoma: the dose is crucial for inhibition of proliferation and induction of apoptosis of melanoma cells.
    Kubo H; Ashida A; Matsumoto K; Kageshita T; Yamamoto A; Saida T
    Arch Dermatol Res; 2008 Jul; 300(6):297-301. PubMed ID: 18324409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of locoregional metastases of malignant melanomas with radiotherapy and intralesional beta-interferon injection.
    Paul E; Müller I; Renner H; Bödeker RH; Cochran AJ
    Melanoma Res; 2003 Dec; 13(6):611-7. PubMed ID: 14646625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma.
    Mastrangelo MJ; Maguire HC; Eisenlohr LC; Laughlin CE; Monken CE; McCue PA; Kovatich AJ; Lattime EC
    Cancer Gene Ther; 1999; 6(5):409-22. PubMed ID: 10505851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of human interferon beta gene therapy for patients with advanced melanoma by in vivo transduction using cationic liposomes.
    Matsumoto K; Kubo H; Murata H; Uhara H; Takata M; Shibata S; Yasue S; Sakakibara A; Tomita Y; Kageshita T; Kawakami Y; Mizuno M; Yoshida J; Saida T
    Jpn J Clin Oncol; 2008 Dec; 38(12):849-56. PubMed ID: 18945721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Present status and problems in the therapy of malignant melanoma].
    Nakayama J
    Fukuoka Igaku Zasshi; 1995 Jan; 86(1):1-5. PubMed ID: 7698716
    [No Abstract]   [Full Text] [Related]  

  • 13. [Adjuvant therapy of primary malignant melanoma with natural human interferon-beta. Significant survival advantage in 96 treated patients in comparison with 288 untreated symptomatic controls].
    Beiteke U; Ruppert P; Garbe C; Oxenfarth R; Kastl I; Türker T; Tronnier H; Frosch PJ
    Hautarzt; 1993 Jun; 44(6):365-71. PubMed ID: 8335459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intralesional monoclonal antibodies effective against melanoma.
    Oncology (Williston Park); 1991 Apr; 5(4):56. PubMed ID: 1831040
    [No Abstract]   [Full Text] [Related]  

  • 15. A phase I trial of recombinant human interleukin-1 beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation.
    Elkordy M; Crump M; Vredenburgh JJ; Petros WP; Hussein A; Rubin P; Ross M; Gilbert C; Modlin C; Meisenberg B; Coniglio D; Rabinowitz J; Laughlin M; Kurtzberg J; Peters WP
    Bone Marrow Transplant; 1997 Feb; 19(4):315-22. PubMed ID: 9051240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in immunological parameters after combination adjuvant therapy with intravenous DTIC, ACNU, and VCR, and local injection of IFN-beta (DAV + IFN-beta therapy) into malignant melanoma.
    Umeda T; Aoki K; Yokoyama A; Ohara H; Hayashi O; Tanaka K; Nishioka K
    J Dermatol; 1998 Sep; 25(9):569-72. PubMed ID: 9798342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellulitis-like skin necrosis induced by postoperative local interferon-β injection for malignant melanoma on the buttock.
    Mori T; Ohashi T; Kikuchi N; Hanami Y; Yamamoto T
    J Dermatol; 2014 Apr; 41(4):364-5. PubMed ID: 24690105
    [No Abstract]   [Full Text] [Related]  

  • 18. Sequential chemoimmunotherapy with cisplatin, interferon-beta and interleukin-2 inhibits the growth of B16-F1 melanoma in syngeneic mice.
    Kubo H; Matsumoto K; Funahashi M; Takagi H; Kitajima Y; Taniguchi S; Saida T
    Melanoma Res; 2000 Jun; 10(3):223-9. PubMed ID: 10890375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two cases of metastatic malignant melanoma of the lower limb treated with hyperthermic isolated limb perfusion and concomitant infusion of either carboplatin or beta-interferon.
    Nakayama J; Takeuchi M; Mayumi H; Nagae S; Matsuda K; Yasui H; Takahashi S; Hori Y
    J Dermatol; 1996 Jan; 23(1):6-15. PubMed ID: 8720252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritumoral injections of interleukin 2 induce tumour regression in metastatic malignant melanoma.
    Gutwald JG; Groth W; Mahrle G
    Br J Dermatol; 1994 Apr; 130(4):541-2. PubMed ID: 8186129
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.